Benzathine penicillin g market share?

There isn’t a single publicly published “market share” figure for benzathine penicillin G. It’s an off-patent, generic injectable antibiotic sold by many manufacturers across different regions, so market share is typically reported regionally or by company in private market research—not as a global, standardized stat.

If you need numbers, I can help you get them by narrowing the scope. Tell me:
- Region (global, US, EU, Asia, etc.)
- Timeframe (last year, last 3 years, etc.)
- Metric (units sold, revenue, or share of a specific segment like long-acting penicillin G)

Possible sources to check:
- Market research reports (IQVIA, GlobalData, Frost & Sullivan, MarketsandMarkets) for “benzathine penicillin G” or “penicillin G benzathine” markets
- Regulatory filings and product catalogs (FDA Orange Book for US approvals; EMA databases in Europe)
- Company annual reports or market updates from major generic manufacturers
- Procurement/tender databases and regional health authorities (for regional supplier shares)

If you want, tell me the region and timeframe you care about, and I’ll help outline a method to estimate the market share or point you to the most relevant sources.